HIV-2 Drug Mutation
Polymorphisms specific to HIV-2 identified in untreated patients
Published in AIDS Weekly, April 11th, 2005
According to a study from France, "Few data are available about the susceptibility and the genotypic resistance pattern of human immunodeficiency virus type 2 (HIV-2) to nucleoside reverse transcriptase inhibitors (NRTIs). The HIV-2 reverse transcriptase (RT) gene from 25 HIV-2-infected patients followed-up in Marseilles and the surrounding area was analyzed.
"The aims of this study were to characterize the polymorphism of HIV-2 RT in the absence of drug, to determine whether it naturally harbors codons associated with drug-resistance in HIV-1 and to identify mutations emerging...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-04-11)
More Articles from AIDS Weekly
- HIV/AIDS Drug Development
Tuftsin-AZT inhibits HIV RT and augments host immunogenic cell function - HIV/AIDS Epidemiology
Low CCR5Delta32 frequency related to higher susceptibility to HIV-1 infection - HIV/AIDS Lipodystrophy
Metabolic and body composition changes vary according to HAART choice - HIV/AIDS Pathogenesis
HIV-1 Vpr inhibits maturation and activation of macrophages and dendritic cells - Arrhythmia
HIV protease inhibitors may predispose patients to cardiac arrhythmias - Avian Influenza
Animal health company launches new Avian Influenza vaccine - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
